Group 7 Copy 3 Created with Sketch.

MENU
Centers
Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous
News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions

Advertisement

Search Results

Refine by Content Type

close Created with Sketch.

Refine by Year

close Created with Sketch.

Sort By:

Relevance Date

Choose Sites to Search:

EVToday EVToday + CIToday

Sponsored by Shape Memory Medical

evt | Article | April 2023

Smart Polymer: Embolization Plus

The versatility of Smart Polymer devices, including the IMPEDE and IMPEDE-FX Embolization Plugs, are highlighted in case examples depicting pulmonary arteriovenous malformation embolization, ovarian and testicular vein embolization, and internal iliac artery embolization as part of iliac artery aneurysm treatment.

With Daniel A.F. van den Heuvel, MD; Sjors Klompmaker, MD, MSc, PhD; Andreas Hadjipolycarpou, MD, MSc; Patrick Knüsel, MD; and Edvard Skripochnik, MD

evt | Article | March 2010

The VIBRANT Trial

Comparing bare-nitinol stents to stent grafts in long superficial femoral artery lesions in this unique trial.

By Gary M. Ansel, MD, FACC; Patrick J. Geraghty, MD, FACS; Mark Mewissen, MD; and Michael R. Jaff, DO

evt | Article | September 2005

An Interview With Gary Ansel, MD

A top interventional cardiologist shares his insight on the future of SFA treatment and what to expect from VIVA 2005.

By Gary Ansel, MD

evt | News | October 21, 2009

Interim 1-Year VIBRANT Results Presented for Gore Viabahn in SFA Treatment

October 22, 2009—In the late-breaking trials session at the Vascular Interventional Advances meeting in Las Vegas, Nevada, Gary M. Ansel, MD, presented 1-year interim results from the VIBRANT (Viabahn Versus Bare-Nitinol Stent) study of the Gore Viabahn endoprosthesis (WL Gore & Associates, Inc., Flagstaff, AZ) in the treatment of long-lesion (≥ 8 cm) superficial femoral artery (SFA) occlusive disease.

Advertisement

evt | Article | June 2018

Creating CLI Teams

The VIVA Physicians' Vascular Leaders Forum offers guidance on core competencies and quality measures for establishing multidisciplinary CLI care teams.

By John H. Rundback, MD; Tony S. Das, MD; Peter A. Schneider, MD; and Michael R. Jaff, DO; on behalf of the VLF participants

evt | Article | September 2019

After the Meta-Analysis…

By Sabine Steiner, MD, and Ramon L. Varcoe, MBBS, MS, FRACS, PhD

evt | Article | July 2006

An Interview With Mark W. Mewissen, MD

A renowned vascular radiologist shares his wisdom about the state of the practice, SFA stenting, and online education.

By Mark W. Mewissen, MD

Sponsored by Silk Road Medical

evt | Article | May 2019

The Shifting Paradigm in Carotid Revascularization: TCAR in Real-World Practice

By Marc Schermerhorn, MD; and Patric Liang, MD; with an accompaniment by Bernardino C. Branco Rocha, MD

Sponsored by Biotronik

evt | Article | September 2018 Supplement

Combining a Drug-Coated Balloon and a Bare-Metal Stent: The REsponse Adapted Combination Therapy (REACT) Strategy

Allowing vessel response to guide appropriate treatment for SFA disease.

By Koen Deloose, MD, and B. Patrice Mwipatayi, MD, MMed, MClinEd, FCS, FRACS

evt | News | November 8, 2009

VIVA 2009 Late-Breaking Trials Highlight Advances in Interventional Treatments of Peripheral Vascular Disease

November 9, 2009—VIVA Physicians, Inc. (San Jose, CA) announced that the latest data from seven studies focused on the treatment of peripheral arterial disease were presented in the late-breaking trials session of the VIVA 2009: Vascular Interventional Advances annual meeting held on October 19 through 23 in Las Vegas, Nevada.

Advertisement

Cardiac Interventions Today
Group 7 Copy 3 Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button